Last CNY34.35 CNY
Change Today +0.34 / 1.00%
Volume 4.9M
002007 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 2:00 AM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

hualan biological engineer-a (002007) Snapshot

Open
CNY34.10
Previous Close
CNY34.01
Day High
CNY34.55
Day Low
CNY33.76
52 Week High
11/27/14 - CNY38.80
52 Week Low
04/29/14 - CNY23.71
Market Cap
20.0B
Average Volume 10 Days
8.2M
EPS TTM
CNY0.94
Shares Outstanding
581.3M
EX-Date
06/20/14
P/E TM
36.5x
Dividend
CNY0.40
Dividend Yield
1.16%
Current Stock Chart for HUALAN BIOLOGICAL ENGINEER-A (002007)

Related News

No related news articles were found.

hualan biological engineer-a (002007) Related Businessweek News

No Related Businessweek News Found

hualan biological engineer-a (002007) Details

Hualan Biological Engineering Inc., a biopharmaceutical company, is engaged in the research, development, production, and commercialization of human blood products, viral vaccines, bacterial vaccines, and recombinant biologics in the People’s Republic of China. Its blood related products include human albumin; human immunoglobulin; human immunoglobulin for intravenous injection; human rabies immunoglobulin; human hepatitis B immunoglobulin; human tetanus immunoglobulin; human prothrombin complex; human coagulation factor VIII; human thrombin, lyophilized for external use; surgical lyophilized fibrin sealant; and human fibrinogen. The company’s vaccines comprise inactivated influenza vaccine; recombinant hepatitis B vaccine; meningococcal polysaccharide vaccine group ACYW135; and influenza A vaccine. It is also involved in the research and development, production, and distribution of genetic engineering products, protein chips, and other biological products, as well as bacterial, viral, and genetic engineering vaccines for human use. The company has a strategic alliance with the Chinese Academy of Sciences and collaborations with various institutes for the discovery of biologics. Hualan Biological Engineering Inc. was founded in 1992 and is based in Xinxiang, the People’s Republic of China.

Founded in 1992

hualan biological engineer-a (002007) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hualan biological engineer-a (002007) Key Developments

Hualan Biological Engineering Inc. to Report Q3, 2014 Results on Oct 31, 2014

Hualan Biological Engineering Inc. announced that they will report Q3, 2014 results on Oct 31, 2014

Hualan Biological Engineering Inc. to Report First Half, 2014 Results on Aug 26, 2014

Hualan Biological Engineering Inc. announced that they will report first half, 2014 results on Aug 26, 2014

Hualan Biological Engineering Inc. to Report Q1, 2014 Results on Apr 26, 2014

Hualan Biological Engineering Inc. announced that they will report Q1, 2014 results on Apr 26, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002007:CH CNY34.35 CNY +0.34

002007 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Beijing Tiantan Biological Products Corp Ltd CNY27.50 CNY -0.59
China Biologic Products Inc $65.42 USD +0.63
Jiangxi Boya Bio-Pharmaceutical Co Ltd CNY65.70 CNY -0.12
Shanghai RAAS Blood Products Co Ltd CNY44.90 CNY +0.22
Sinovac Biotech Ltd $5.11 USD +0.16
View Industry Companies
 

Industry Analysis

002007

Industry Average

Valuation 002007 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 36.0x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HUALAN BIOLOGICAL ENGINEER-A, please visit www.hualanbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.